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Induced pluripotent stem cells (iPSCs) are commonly
generated by transduction of Oct4, Sox2, Klf4, and
Myc (OSKM) into cells. Although iPSCs are pluripo-
tent, they frequently exhibit high variation in terms
of quality, as measured in mice by chimera contribu-
tion and tetraploid complementation. Reliably high-
quality iPSCs will be needed for future therapeutic
applications. Here, we show that one major determi-
nant of iPSC quality is the combination of reprogram-
ming factors used. Based on tetraploid complemen-
tation, we found that ectopic expression of Sall4,
Nanog, Esrrb, and Lin28 (SNEL) in mouse embryonic
fibroblasts (MEFs) generated high-quality iPSCs
more efficiently than other combinations of factors
including OSKM. Although differentially methylated
regions, transcript number of master regulators,
establishment of specific superenhancers, and
global aneuploidy were comparable between high-
and low-quality lines, aberrant gene expression,
trisomy of chromosome 8, and abnormal H2A.X
deposition were distinguishing features that could
potentially also be applicable to human.
INTRODUCTION
Recent reports indicate that the majority of OSKM-derived
iPSCs may have reduced differentiation potential as compared
to embryonic stem cells (ESCs) derived by somatic cell nuclear
transfer (SCNT), which are equivalent in their developmental po-
tential to ESCs derived from the fertilized egg (Boland et al.,Cell S2009; Brambrink et al., 2006; Jiang et al., 2011, 2013; Kang
et al., 2009; Kim et al., 2010; Pera, 2011; Polo et al., 2010;
Zhao et al., 2009). In addition, it has been suggested that
OSKM-derived iPSCs exhibit genetic and epigenetic aberrations
throughout the genome that are distinct from ESCs (Bar-Nur
et al., 2011; Chin et al., 2009; Doi et al., 2009; Gore et al.,
2011; Hussein et al., 2011; Kim et al., 2010, 2011; Laurent
et al., 2011; Lister et al., 2011; Mayshar et al., 2010; Ohi et al.,
2011; Phanstiel et al., 2011; Polo et al., 2010). These data are
consistent with the prevailing current reprogramming method
affecting the quality of the resulting pluripotent cells. Several pa-
rameters have been shown to affect the quality of iPSCs, such as
factor stoichiometry (Carey et al., 2011), culture condition, and
supplements used to derive the cells (Chen et al., 2011). For
example, by comparing two genetically defined transgenic sys-
tems to identify parameters affecting reprogramming, it has
been shown that high levels of Oct4 and Klf4, together with
low levels of Sox2 and Myc, are favorable with respect to the
quality of the iPSCs even though a much lower reprogramming
efficiency was observed when compared to high levels of Sox2
and Myc and low levels of Oct4 and Klf4 (Carey et al., 2011).
Also, derivation of iPSCs in the absence of serum but in the pres-
ence of vitamin C improved the quality of the cells and generated
tetraploid complementation-competent iPSCs even when a sub-
optimal factor stoichiometry was used to induce pluripotency
(Esteban and Pei, 2012; Stadtfeld et al., 2012). In summary, the
available data suggest that factor stoichiometry, as well as spe-
cific culture conditions, affect the quality of iPSCs. Here, we
show that the quality of iPSCs is dramatically affected by the
specific choice of reprogramming factors. Reprogramming by
Sall4, Nanog, Esrrb, and Lin28 (SNEL) generated a very low num-
ber of iPSC colonies, themajority of which were of high quality as
defined by their capacity to produce healthy ‘‘all-iPSC’’ mice, as
determined by 4n complementation, the most stringent test for
pluripotency. In stark contrast, OSKM produced a large numbertem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier Inc. 295
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exhibited low developmental potential. Removing Myc from the
cocktail (OSK) yielded a higher number of high-quality iPSCs,
indicating that the present of Myc in the reprogramming factors
combination has a negative effect on iPSCquality. Surprisingly, a
combination of Oct4, Sox2, Sall4, Nanog, and Esrrb (OSSNE),
although lacking potent oncogenes like Myc and Lin28, yielded
the highest number of poor quality iPSCs, suggesting that the
interplay between the reprogramming factors plays a critical
role in the reprogramming process as well. To shed light on the
elements that dictate successful reprogramming events, we per-
formed a large number of genomic and epigenomic analyses.
While whole genome transcriptional profile, methylome analysis,
establishment of superenhancers, or single-cell analysis of key
master regulator transcript number and global aneuploidy did
not distinguish between poor- and high-quality iPSCs, aberrant
expression of 1,765 genes, trisomy of chromosome 8, and
abnormal H2A.X deposition were frequently observed in poor-
quality iPSCs that were derived by OSKM or OSK. Our results
demonstrate that the selection of the reprogramming factor
combination is an important determinant for retaining genomic
integrity, appropriate transcriptional resetting, and functional
pluripotency of iPSCs.
RESULTS
Ectopic Expression of Sall4, Nanog, Esrrb, and Lin28
Activates the Endogenous Pluripotency Circuitry
Recently, using two complementary single-cell technologies, we
have demonstrated that the reprogramming process involves a
late hierarchical/deterministic phase that starts with the activa-
tion of the Sox2 locus and continues with a series of gene activa-
tion events that lead to a stable and transgene-independent plu-
ripotency state (Figure 1A) (Buganim et al., 2012, 2013; Klemm
et al., 2014; Pan and Pei, 2012). We reasoned that a combination
of key factors derived from this later phase would reprogram
cells in a more controlled manner and potentially would then uni-
formly yield iPSCs of high quality. We focused mainly on one
specific combination of factors, Sall4, Nanog, Esrrb, and Lin28
(SNEL), because we wished to avoid ectopic expression of the
key master regulators Oct4 and Sox2. We hypothesized that
exogenous expression of strong key master regulators such as
Oct4 and Sox2, without their endogenous regulators present in
ESCs or during nuclear transfer-mediated reprogramming in
the oocyte, might yield aberrant activation of various loci in the
somatic cell genome that interfere with normal reprogramming
events as is apparent in partially reprogrammed cells (Buganim
et al., 2012, 2013). Sall4 and Esrrb were chosen based on a
Bayesian network analysis prediction that they could activate
the endogenous Oct4 and Sox2 genes, respectively. We
selected Lin28 because it has been shown to act as a global
mRNA regulator (Cho et al., 2012) and to activate the de novo
DNA methyltransferase, Dnmt3b, and Nanog that was predicted
to have a separate role during reprogramming (Figure 1A).
Nanog-GFP or Oct4-GFP mouse embryonic fibroblasts (MEFs)
were introduced with doxycycline (dox)-inducible lentiviruses
encoding for the SNEL reprogramming factors and cultured until
the formation of iPSC colonies. The efficiency of the reprogram-
ming process was very low, producing one to five colonies per296 Cell Stem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier I1 3 105 plated cells with a latency that ranged between 14–
60 days. In total, we isolated ten SNEL-iPSC colonies (six from
Nanog-GFP and four from Oct4-GFP MEFs). The resulting
iPSC colonies expressed a bright GFP signal from both the
Oct4 and the Nanog locus and showed upregulation of key plu-
ripotency markers such as Sox2, endogenous Sall4, Utf1, and
endogenous Esrrb, as assessed by immunostaining (Figure 1B).
A comparable mRNA level to OSKM-iPSCs and several ESC
lines of Dppa2, Dppa3, endogenous Lin28, and Rex1 was noted
as well by quantitative real-time PCR (qRT-PCR) (Figure 1C).
When injected into NOD/SCID mice, the cells formed well-differ-
entiated teratomas with structures from all three germ layers
(representative images can be seen in Figure 1D).
SNEL-iPSCs Contribute to High-Grade Chimeras
and Frequently Produce ‘‘All-iPSC’’ Mice
The potential of SNEL-iPSCs to generate chimeras was tested
by injecting cells from all ten clones into host blastocysts that
were subsequently transferred into pseudopregnant recipient
females. All lines gave rise to chimeras, with 8/10 (80%) gener-
ating high-grade chimeras (50%–95%) as assessed by coat
color (Figures S1A and S1B available online). Germline transmis-
sion was noted in all five tested lines (Figures S1A and S1C).
Chimeric mice from one of the iPSC clones (Oct4-GFP
SNEL#2) suffered from an eye problem and one adult mouse
developed a tumor. However, these isolated events might be ex-
plained by leaky expression of Esrrb and Lin28, which have been
linked to similar phenotypes (Audo et al., 2012; Viswanathan
et al., 2009; West et al., 2009). All other chimeras generated
from independent clones grew to old age without any obvious
evidence of tumorigenicity (Figure S1C). To stringently compare
the developmental potential of SNEL and OSKM-derived iPSCs,
we performed 4n complementation assay. Utilizing identical
infection and culture conditions as used for the derivation of
the SNEL-iPSCs, ten iPSC lines were derived by infection of
MEFs with OSKM lentiviruses all of which expressed high levels
of GFP and pluripotency markers (6/10 of the colonies are pre-
sented in Figure 1C). Cells from the ten SNEL-iPSC and ten
OSKM-iPSC lines were injected into 4n blastocysts and trans-
ferred into pseudopregnant recipient females. The SNEL-iPSCs
produced approximately five times asmany live 4n pups with the
majority surviving postnatally (p = 3.46 3 1012 by c2 test) (Fig-
ures 2A and 2B; Table S1) as compared to OKSM-iPSCs. Out of
a total of 1,495 OSKM-iPSC-injected blastocysts, only 21 (1.4%)
were delivered, 11 (0.7%) of which sustained normal breathing
and were foster nursed. In contrast, out of 2,138 blastocysts in-
jected with SNEL iPSCs, 149 (7%) survived to birth, 109 (5%) of
which were breathing normally and were fostered nursed (Table
S1). In total, 40% of the OSKM-iPSC lines gave rise to live
pups, compared to 80% of the SNEL-iPSC lines. In general,
the adult ‘‘all-SNEL-iPSC’’ mice were healthy and fertile (Figures
2B and S2C), although some mice exhibited some phenotypes
that are purely related to leaky expression of Lin28, such as
long tail and ears and flattened nose as described in (Zhu
et al., 2010, 2011), and several individuals died prematurely after
1 year. To exploit the maximum potential of the cells and deter-
mine whether the developmental differences between these two
types of iPSCs would be further exacerbated, we cultured the 20
iPSC lines in 2i medium (LIF, GSK3b, and Mek 1/2 inhibitorsnc.
Figure 1. Characterization of SNEL-iPSC Lines
(A) Schematic presentation of Bayesian network demonstrates the hierarchy of a subset of pluripotent genes that leads to a stable and transgene independent
pluripotency state (Buganim et al., 2012). Sall4, Nanog, Esrrb, and Nanog (SNEL) are marked by a red circle.
(B) Representative images of two stable dox-independent, GFP-positive colonies (Nanog-GFP SNEL#1 and Oct4-GFP SNEL#3) and immunostaining for Sall4,
Sox2, Utf1, and Esrrb.
(C) Heatmap demonstrating the relative expression levels of Dppa3, Dppa2, Zfp42 (Rex1), and Lin28 normalized to the Hprt housekeeping control gene in the
indicated samples.
(D) Hematoxylin and eosin staining of teratoma sections generated from Oct4-GFP SNEL#1 showing structures from all three layers.
See also Figure S1.
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Figure 2. SNEL-iPSCs Produce ‘‘All-iPSC’’ Mice with High Success Rates as Compared to OSKM
(A) Percent of injected blastocysts surviving to birth are plotted for OSKM and SNEL lines, with the number of blastocysts noted on the x axis. Blue represents the
number of pups thatmerely survived delivery, red the number of pups additionally foster-nursed. Percentageswere compared by c2 test to compute significance.
(B) Representative images of 4n adult mice produced from Oct4-GFP SNEL#1 and Oct4-GFP SNEL#4 lines and their F1 generation.
(C) Confirmation of origin of ‘‘all-iPSC’’mice by PCR for strain-specific polymorphisms. Two different simple sequence polymorphism (SSLP)markers were tested
using genomic DNA isolated from tissues of ‘‘all-iPSC’’ mice. Genomic DNA from the parental iPSCs (donor cells), a 129 Sv/Jae mouse (donor strain), and a
B6D2F1 mouse (host blastocyst strain) served as controls.
See also Figure S2.
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into 60 4n blastocysts. The percentage of live-born pups in the
SNEL combination was significantly higher, reaching 23%–
25% in some SNEL-iPSC lines (Table 1 and Figures S2A and
S2B). From a total of 600 OSKM-iPSC-injected blastocysts
only 13 (2.1%) were delivered, eight (1.7%) of which sustained
normal breathing and were foster nursed. In contrast, out of
600 blastocysts injected with SNEL-iPSCs, 64 (10.7%) survived
to birth, 51 (8.5%) of which were breathing normally and were
fostered nursed (Table 1). Germline transmission was noted in
all examined lines. Simple sequence length polymorphism
(SSLP) analysis for ten randomly selected 4n embryos (PCR-
based assay for two loci) confirmed that the embryos were solely
derived from the injected iPSCs (Figure 2C). Our data suggest
that reprogramming with SNEL, in contrast to reprogramming
using OSKM under the same conditions, produces high-quality
iPSCs at high rates as assessed by the most stringent test of
4n complementation.
Myc is a potent oncogene that affects genomic integrity when
deregulated (Barlow et al., 2013) and enhances the transcription298 Cell Stem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier Iat all active promoters when overexpressed (Lin et al., 2012; Nie
et al., 2012). To determine whether overexpression of Myc is the
cause for the high number of poor quality OSKM-iPSC colonies,
we derived ten OSK-iPSC colonies under identical conditions
and assessed their quality by 4n complementation. Indeed, a
larger number of colonies (8/10 in OSK-iPSC colonies compared
to 4/10 inOSKM-iPSC colonies) passed the 4n complementation
test. However, a significantly lower number of pups were deliv-
ered per line (30 live pups, 5%) in colonies derived from OSK
compared to colonies derived from SNEL (64 live pups,
10.7%). These results indicate that Myc is partially responsible
for the high number of poor quality colonies in the OSKM combi-
nation but suggest that other parameters influence the quality, as
well. We then sought to determine whether potent oncogenes
are the main reason for the generation of poor quality iPSCs.
To test this hypothesis, we isolated 6 colonies, generated by
ectopic expression of Oct4, Sox2, Sall4, Nanog, and Esrrb
(OSSNE) but without the potent oncogenes Myc and Lin28. Sur-
prisingly, OSSNE combination yielded the highest number of
poor quality iPSCs (five live pups, 1.3%), suggesting that thenc.
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element during the reprogramming process.
Comparative Transcriptome Profiling of Poor- and High-
Quality iPSCs Reveals a Distinct Signature of 1,765
Genes that Robustly Distinguish Lines by 4n Proficiency
To reveal a gene expression signature associated with develop-
mental competence, we selected the following groups of iPSC
lines for microarray analysis: (1) ‘‘poor quality’’ iPSCs: this group
included the three OSKM-iPSC lines Nanog-GFP OSKM#2,
Oct4-GFP OSKM#2, and KH2 OSKM (Stadtfeld et al., 2010),
that either did not produce fully developed pups or produced
very low number of pups; (2) ‘‘good quality’’ iPSCs: this group
included BC_2 OSKM (Carey et al., 2011) and Nanog-GFP
SNEL#3, both of which gave rise to live, normal pups that sur-
vived only a few hours; (3) ‘‘high quality’’ iPSCs consisting of
Nanog-GFP SNEL#2 and Oct4-GFP SNEL#1, both of which
generated live pups that survived postnatally (representative
pups from each iPSC group are shown in Figure S3A). We
used Nanog-GFP, Oct4-GFP, and KH2 (Beard et al., 2006)
ESCs as controls.
Whole genome transcriptional analysis did not distinguish be-
tween the groups as assessed by hierarchical clustering and
principle component analysis (PCA), consistent with their com-
mon identities as pluripotent cells (Figures 3A and S3B). In
contrast, unbiased hierarchical clustering and PCA analysis of
differentially expressed genes between all groups (F test, p <
0.01, Table S2) revealed a list of 1,765 genes that separated
perfectly the different groups and clustered the ‘‘poor quality’’
group away from the other three groups (Figures 3B and 3C).
qRT-PCR for two representative differentially expressed genes,
Col6a1 and Thsb1, from the 1,765 gene signature demonstrated
a trend of expression that is highly correlated with 4n compe-
tency (Figure 3D).
Gene ontologies and pathways (GeneDecks) (Stelzer et al.,
2009) for the 1,765 differentially expressed genes revealed
enrichment not only for categories associated with the control
of cellular growth and division, but also for more refined and spe-
cific developmental pathways and phenotypes: respiratory, im-
mune, musculature, and aortic integrity phenotypes; hypoxia,
myocardial infarction, and pulmonary disease; abnormal limb/
digit/tail morphology; genes involved in extracellular matrix
composition and TGFb signaling; and defective embryogenesis
(the p value and number of genes of representatives categories
are presented in Figure 3E). Standard motif enrichment analysis
on the 1,765 gene promoters revealed a strong enrichment for
transcription factors vital for early embryonic development and
ESC self-renewal (Hanna et al., 2002; Liu and Labosky, 2008;
Shah et al., 2012; Weinhold et al., 2000) such as Foxd3, HMG-
I/Y, and Srf (Figure S3C), lending support to the role of the
1,765 genes in development and ESC maintenance.
Differentially Methylated Regions and the
Establishment of ESC-Specific Superenhancers Cannot
Distinguish between Poor- and High-Quality iPSCs
To assess whether this gene expression pattern may be associ-
ated with epigenetic alterations, we profiled the methylomes of
these samples by whole genome bisulfite sequencing. Although
over 2,500 differentially methylated regions (DMRs) were identi-Cell Sfied, these were largely specific to individual iPSC lines (i.e.,
Nanog-GFP versus Oct4-GFP lines, Figure 3F). Thus, the exclu-
sively intronic and intergenic genomic distribution of DMRs
precluded accurate assessment of any contribution of DNA
methylation to the observed gene expression pattern.
To test whether variations in the transcript levels of ESC key
master regulators could explain the differences in the gene
expression pattern between poor- and high-quality iPSCs, we
employed the single-molecule-mRNA fluorescent in situ hybrid-
ization (sm-mRNA-FISH) technique, which allows the quantifica-
tion of mRNA transcripts of up to three genes in individual cells
(Raj et al., 2010). The transcript number of three ESC key master
regulators, Oct4, Sox2, and Esrrb, was quantified in two poor
quality OSKM-iPSC lines, Nanog-GFP OSKM#3 and Oct4-GFP
OSKM#4, and two high-quality SNEL-iPSC lines, Nanog-GFP
SNEL#2 and Oct4-GFP SNEL#3. As depicted in Figures 4A
and S4A, the transcript count of all three factors was comparable
between the different lines. It should be noted that the transcript
count of Esrrb was lower in the Nanog-GFP lines as compared to
Oct4-GFP lines (Figures 4A and S4B). This result is consistent
with the previous observation that Esrrb is a direct target of
Nanog (Festuccia et al., 2012), as in our system GFP was intro-
duced into the Nanog locus by replacing the coding region of
the endogenous Nanog gene, thereby creating a mutant allele
which reduces the total level of endogenous Nanog protein.
Superenhancers are regulatory elements that are associated
with genes that determine cell identity (Hnisz et al., 2013).
Therefore, the establishment of ESC-specific superenhancers
during the reprogramming process is crucial to allow proper
transcription and function. It has been shown that the binding
of key master regulators, H3K27ac and the Mediator complex
rigorously mark superenhancers (Whyte et al., 2013). To test
whether poor quality iPSCs acquire aberrant establishment of
superenhancers during the reprogramming process, we
measured the enrichment of the Mediator complex on ESC-
specific superenhancers by chromatin immunoprecipitation
sequencing (ChIP-seq) in several lines. ChIP-seq for Med1, a
component of the Mediator complex, was performed on two
ESC lines, V6.5 and ZHBcT4, as positive controls, the parental
MEFs and two previously described partially reprogrammed
lines (i.e., cells that initiated the reprogramming process but
never gave rise to stable iPSCs, 23 and 44) as negative controls
(Buganim et al., 2012), three poor quality iPSC lines, Nanog-
GFP OSKM#2, Oct4-GFP OSKM#4, and Oct4-GFP OSKM#8,
and two high-quality iPSC lines, Oct4-GFP SNEL#3 and Oct4-
GFP SNEL#4. The distribution of the Mediator complex
throughout the genome was compared to the distribution of
the binding of Oct4, Sox2, and Nanog (OSN), three ESC key
master regulators. The recruitment of Med1 protein throughout
the genome was comparable in all iPSC lines tested but was
absent in the negative control cells as can be seen in three
representative ESC-specific superenhancers for Sox2, Nanog,
and miR290-295, (Figures 4B and S4C) and following hierarchi-
cal clustering analysis of Med1 densities in all superenhancers
from all lines (Figure 4C). The results so far indicate that both
poor- and high-quality iPSCs reach a complete activation of
the endogenous pluripotency circuitry as measured by tran-
script count of ESC key master regulators and by establishment
of ESC-specific superenhancers.tem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier Inc. 299
Table 1. Generation of ‘‘All-iPSC’’ Mice Produced by Various Combinations of Reprogramming Factors
Cell Line Injected Embryos Recipient Females Implantation Sites Dead Fetuses and Pupsa (%) Pups Born Aliveb (%) Fostered Pupsc (%)
Oct4-GFP SNEL#1 60 3 6 1 (1.6) 2 (3.3) 1 (1.6)
Oct4-GFP SNEL#2 60 3 9 3 (5.0) 9 (15.0) 8 (13.3)
Oct4-GFP SNEL#3 60 3 9 2 (3.3) 14 (23.3) 13 (21.6)
Oct4-GFP SNEL#4 60 3 15 3 (5.0) 11 (18.3)d 6 (10.0)
Nanog-GFP SNEL#1 60 3 18 1 (1.6) 9 (15.0) 8 (13.3)
Nanog-GFP SNEL#2 60 3 12 0 (0.0) 15 (25.0) 14 (23.3)
Nanog-GFP SNEL#3 60 3 22 2 (3.3) 2 (3.3) 1 (1.6)
Nanog-GFP SNEL#4 60 3 3 0 (0.0) 0 (0.0) 0 (0.0)
Nanog-GFP SNEL#5 60 3 7 0 (0.0) 0 (0.0) 0 (0.0)
Nanog-GFP SNEL#6 60 3 22 1 (1.6) 2 (3.3) 0 (0.0)
Total (Average) 60 3 13.3 1.3 (2.1) 6.4 (10.7) 5.1 (8.5)
Oct4-GFP OSKM#2 60 3 18 0 (0.0) 4 (6.6)d 2 (3.3)
Oct4-GFP OSKM#3 60 3 16 0 (0.0) 5 (8.3)e 3 (5.0)
Oct4-GFP OSKM#4 60 3 37 1 (1.6) 0 (0.0) 0 (0.0)
Oct4-GFP OSKM#5 60 3 12 0 (0.0) 0 (0.0) 0 (0.0)
Oct4-GFP OSKM#6 60 3 29 1 (1.6) 1 (1.6) 1 (1.6)
Oct4-GFP OSKM#7 60 3 25 1 (1.6) 3 (5.0) 2 (3.3)
Oct4-GFP OSKM#8 60 3 16 0 (0.0) 0 (0.0) 0 (0.0)
Nanog-GFP OSKM#1 60 3 12 0 (0.0) 0 (0.0) 0 (0.0)
Nanog-GFP OSKM#2 60 3 24 0 (0.0) 0 (0.0) 0 (0.0)
Nanog-GFP OSKM#3 60 3 11 0 (0.0) 0 (0.0) 0 (0.0)
Total (average) 60 3 20 0.3 (0.48) 1.3 (2.1) 0.8 (1.7)
Oct4-GFP OSK#1 60 3 14 0 (0.0) 3 (5.0) 3 (5.0)
Oct4-GFP OSK#2 60 3 18 2 (3.3) 2 (3.3) 2 (3.3)
Oct4-GFP OSK#3 60 3 13 0 (0.0) 2 (3.3) 2 (3.3)
Oct4-GFP OSK#4 60 3 3 2 (3.3) 13 (21.6) 13 (21.6)
Oct4-GFP OSK#5 60 3 0 5 (8.3) 5 (8.3)d 4 (6.6)
Oct4-GFP OSK#6 60 3 6 0 (0.0) 1 (1.6) 1 (1.6)
Oct4-GFP OSK#7 60 3 10 0 (0.0) 1 (1.6) 1 (1.6)
Oct4-GFP OSK#8 60 3 3 0 (0.0) 3 (5.0) 3 (5.0)
Oct4-GFP OSK#9 60 3 14 0 (0.0) 0 (0.0) 0 (0.0)
Oct4-GFP OSK#10 60 3 28 0 (0.0) 0 (0.0) 0 (0.0)
Total (Average) 60 3 11 0.9 (1.49) 3 (5.0) 2.9 (4.8)
Oct4-GFP OSSNE#1 60 3 31 0 (0.0) 0 (0.0) 0 (0.0)
Oct4-GFP OSSNE#2 60 3 4 0 (0.0) 2 (3.3) 2 (3.3)
Oct4-GFP OSSNE#3 60 3 5 0 (0.0) 3 (5.0) 0 (0.0)
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Cell STrisomy of Chromosome 8 Is a Frequent Genomic
Aberration in OSKM/OSK-iPSC Lines
It has been demonstrated that oncogenic stress induced by Myc
leads to DNA damage that promotes genomic instability and
tumor progression (Vafa et al., 2002). To test whether OSKMelicit
stronger DNA damage than SNEL when overexpressed, we in-
fected MEFs with either OSKM, SNEL, or an empty vector as
control and measured the levels of a well-known DNA damage
sensor, g-H2A.X phosphorylation (Bonner et al., 2008) 7 days
postdox exposure. Consistent with Myc being a very potent
oncogene (Gonza´lez et al., 2013; Mario´n et al., 2009; Mu¨ller
et al., 2012), we observed a significant increase in g-H2A.X phos-
phorylation level in OSKM-infected MEFs as compared to MEFs
thatwere infectedwith empty vector or SNEL (Figure 5A).Consis-
tent with that, a large fraction of propidium iodide-positive cells
(10.9%) was observed in OSKM-infected MEFs, but not in
SNEL or empty vector-infected MEFs, suggesting that OSKM
expression leads to severe DNA damage that induces cell death
(Figure 5B). This result led us to investigate whether OSKM-
iPSCs acquire genomic aberrations throughout the reprogram-
ming process, which might explain the premature death
observed in 4n embryos produced by the poor quality OSKM-
iPSCs. DNA rearrangements such as sister chromatid ex-
changes (SCEs) are sensitive indicators of genomic stress and
instability, thus, we mapped SCEs using Strand-seq (Falconer
et al., 2012). It has been shown that, at most, three ESCs eventu-
ally contribute to the formation of a 2n or 4n embryo out of 8–12
injected cells (Wang and Jaenisch, 2004). Thus, an iPSC clone
that contains even only a few cells with genomic aberrations
might still exhibit poor developmental potential. To overcome
the heterogeneity observed within an iPSC colony, wemeasured
SCEs at the single-cell level as opposed to the majority of
the studies in the field thatmeasured genomic instability of iPSCs
by employing population-based analyses. Single cell sequencing
libraries were made from MEFs, ESCs, two poor quality iPSC
lines, Oct4-GFP OSKM#4 and Oct4-GFP OSKM#8, and two
high-quality iPSC lines, Oct4-GFP SNEL#3 and Oct4-GFP
SNEL#4, and SCE frequencywas examined. As shown in Figures
5C, S5A, and S5B, both SNEL lines fall between the two OSKM
lines, revealing no difference in SCE counts between the
OSKM- and SNEL-iPSCs. We then hypothesized that long tran-
sient genomic instability during reprogramming could generate
cells with higher susceptibility to acquire chromosomal aberra-
tions. To that end, we also examined the chromosome content
by single cell sequencing. Interestingly, as observed previously
for poor quality ESCs, trisomy of chromosome 8 was detected
in the majority of the Oct4-GFP OSKM#8 iPSCs. To test whether
trisomy 8 is a common aberration in iPSC lines, single cell
sequencing libraries were made from 22 cell lines (one ESC
line, eight OSKM lines, six OSK lines, and seven SNEL lines)
that were cultured for only five passages. For each colony, single
cells were sorted and sequenced. Out of the eight OSKM lines
analyzed, three showed cells with trisomy 8: 6% of the Nanog-
GFP OSKM#3 cells, 91% of the Nanog-GFP OSKM#2, and
95% of the Oct4-GFP OSKM#8 (Figure 5D). Out of the six OSK
lines, four showed cells with trisomy 8: 4% of the Oct4-GFP
OSK#8 cells, 8% of Oct4-GFP OSK#7, 8% of Oct4-GFP
OSK#10, and 95% of Oct4-GFP OSK#9. No trisomy of chromo-
some 8 was detected in any of the other lines tested (Figures 5D,tem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier Inc. 301
Figure 3. Unbiased Comparative Transcriptome Analyses Distinguish iPSCs According to Their 4n Proficiency
(A) Hierarchical clustering of global gene expression profiles for two microarray technical replicates for every iPSC and ESC (reference) line. Replicate pairs were
assigned a shared numerical value.
(B) Hierarchical clustering of all genes (n = 1,765) exhibiting significant variation (p < 0.01 by F test) across all ESC and iPSC samples.
(C) Principle component analysis for genes from (B). Each of the iPSC and ESC groups is marked by specific color and is surrounded by a circle. The numbers
inside the circles correspond to the numbers in (A).
(D) qRT-PCR of theCol6a1 and Thsb1 normalized to theHprt housekeeping control gene in the indicated samples. Error bars are presented as amean ± SDof two
duplicate runs from a typical experiment. The numbers on the x axis correspond to the numbers in (A).
(E) Gene ontology analysis using the GeneDecks (Stelzer et al., 2009) algorithm of genes from (A).
(F) Hierarchical clustering of 2,628 differentially methylated regions (DMRs) derived from whole genome bisulfite sequencing does not segregate samples by
either reprogramming factor combinations or ESC versus iPSC status. Each group (poor, good, high, and ESCs) is marked by a different color. Sample numbers
correspond to the numbers in (A).
See also Figure S3.
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Generation of High-Quality iPSCsS5C, and S5D). On average, 21% of the OSKM cells and 19% of
the OSK cells had a trisomy 8, versus 0% in the SNEL cells and
the ESCs (p = 0.002 and p = 0.005, respectively). We also exam-
ined whether we could detect any clear difference in the fre-
quency of aneuploidy between the lines once trisomy 8 was
excluded from the analysis. On average, OSKM lines attained a
10% frequency of aneuploidy compared with 13% for the OSK
lines, 9% for the SNEL lines, and 9% for the ESC line (differences302 Cell Stem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier Iare not significant). These results suggest that trisomy 8 is a com-
mon aberration in iPSCs-derived from a combination of factors
that includes the key factors, Oct4, Sox2, and Klf4.
High-Quality SNEL-iPSCs Are Correlated with Faithful
H2A.X Deposition Patterns
Defective H2A.X deposition frequently occurs in iPSC clones
generated by OSKM factors that failed to support ‘‘all-iPS’’nc.
Figure 4. The Transcript Number of Key Master Regulators and the Establishment of ESC-Specific Superenhancers Are Comparable
between Poor- and High-Quality iPSCs
(A) sm-mRNA-FISH experiments depict the transcript number of Oct4 versus Sox2 and Oct4 versus Esrrb in single cells from the indicated iPSC lines. n, rep-
resents the number of single cells analyzed.
(B) ChIP-seq binding profiles for Oct4, Sox2, and Nanog (merged, OSN) in V6.5 mESCs and Med1 for the indicated cell lines at the Sox2 locus. Location of the
superenhancer, as defined in V6.5 mESCs (Whyte et al., 2013), is indicated by the red bar. Rpm/bp, reads per million per base pair.
(C) Hierarchical clustering of Med1 densities in superenhancers recapitulates phylogeny of cell types. ChIP-seq read densities for Med1 were calculated in mES
superenhancers. Clustering these densities indicates that cell types of similar origin have similar signal of Med1 in superenhancers. All ChIP-seq was performed
with a Bethyl Laboratories antibody (A300-793A, lot A300-783A), except for the farthest right V6.5 ChIP, which was performed with a Santa Cruz Biotechnology
antibody (SC-5334X, lot A1112).
See also Figure S4.
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Generation of High-Quality iPSCsmice development in tetraploid complementation experiments
(Wu et al., 2014). In addition, our results suggest that ectopic
expression of OSKM in MEFs induces a strong DNA damageCell Sresponse that leads to the accumulation of g-H2A.X phosphor-
ylation (Figure 5A). We therefore hypothesized that the
genome-wide H2A.X deposition patterns might be intact intem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier Inc. 303
Figure 5. Trisomy of Chromosome 8 Is a Frequent Genomic Aberration in Poor-Quality OSK/OSKM-iPSCs
(A) Western blot analysis for the DNA damage sensor, g-H2A.X phosphorylation, and the housekeeping control protein Gapdh, 7 days postdox exposure in MEFs
infected with the indicated dox-inducible reprogramming factors.
(B) FACS analyses demonstrating the percentage of cells from (A) that initiated the apoptotic process as assessed by PI and Annexin V.
(C) Graph summarizing the average number of sister chromatid exchanges (SCEs) occurring at the single cell level in the indicated lines using the Strand-seq
technique. n, represents the number of single cells tested. Error bars are presented as a mean ± SD of the indicated ‘‘n’’ examined single cells.
(D) Graph summarizing the frequency of trisomy 8 observed in the indicated colonies.
See also Figure S5.
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Generation of High-Quality iPSCshigh-quality SNEL-iPSCs, while abnormal in poor quality
OSKM-iPSCs and OSK-iPSCs. To test this hypothesis, we per-
formed ChIP-seq for H2A.X on two poor quality OSKM-iPSC
lines, Oct4-GFP OSKM#5 and Oct4-GFP OSKM#8, two high-
quality SNEL-iPSC lines, Oct4-GFP SNEL#1 and Oct4-GFP
SNEL#3, two high-quality OSK-iPSC lines, Oct4-GFP OSK#4
and Oct4-GFP OSK#2, and one poor quality OSK-iPSC line,
Oct4-GFP OSK#9, and compared them to the parental Oct4-
GFP ESCs. We used an established Hidden-Markov-Model
(HMM) algorithm (Song and Smith, 2011) to inspect the differ-
ential H2A.X deposition regions in these cells (Wu et al.,
2014). H2A.X deposition patterns in the high-quality Oct4-
GFP SNEL#1 and SNEL#3 iPSC lines, were almost identical
to the parental Oct4-GFP ESC line. Moreover, the number of
H2A.X devoid regions was significantly lower in SNEL-iPSCs
even compared to the control ESC line; devoid regions that
mark the natural variations between ESC (e.g., the parental
Oct4-GFP ESC versus 129SVj/c57 ESC control line) (Figures
6A and 6C). In contrast, H2A.X deposition patterns were greatly
different in poor quality lines, Oct4-GFP OSKM#5, Oct4-GFP
OSKM#8, and another iPSC cell line (OSKM_test) generated
by the secondary inducible system that failed tetraploid
complementation assays (Stadtfeld et al., 2010); these clones
had significantly more differential H2A.X deposition regions
than the high-quality SNEL-iPSC clones in terms of the genome
coverage (100- to 400-fold, p value < 0.05, Wilcoxon test, Fig-
ures 6A and 6B). The same trend was observed in the OSK-304 Cell Stem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier IiPSC lines. H2A.X deposition patterns were also greatly
different in the poor quality line (p value < 0.05, Wilcoxon
test, Figure 6C) and comparable to control ESCs in the high-
quality OSK-iPSC lines. However, the differences between
the high-quality OSK-iPSC lines and the parental Oct4-GFP
ESC line were still greater than those between SNEL-iPSCs
and the same parental ESCs. These results demonstrate a
strong correlation between the capability to produce ‘‘all-
iPSC’’ mice and the capability to faithfully recapitulate an intact
H2A.X deposition. These data raise the possibility that SNEL
reprogramming factors can generate frequently high-quality
iPSCs by retaining intact H2A.X deposition throughout the
genome.
DISCUSSION
Tetraploid complementation is considered to be the most strin-
gent assay for pluripotency and is frequently used to assess
the quality of iPSCs. Even though iPSCs have been shown by
several laboratories to be 4n competent, only a small fraction
of the tested lines passed this most stringent test (Boland
et al., 2009; Jiang et al., 2011, 2013; Kang et al., 2009; Pera,
2011; Zhao et al., 2009). Our experiments show that the rate of
high-quality iPSCs as assessed by 4n competence is signifi-
cantly influenced by the choice of factors used to induce reprog-
ramming. We demonstrate that the SNEL factors, which are
downstream targets of the late pluripotency factor Sox2nc.
Figure 6. H2A.X Deposition Pattern Can Distinguish SNEL and OSK or OSKM iPSC Lines
(A) The bar chart illustrates that the genome coverage of defective H2A.X deposition regions in OSKM-iPSC lines (n = 3) are significantly higher than those in 4N+
SNEL-iPSC lines (n = 2) or the ESC control line (p value < 0.05, Wilcoxon rank sum test).
(B) Comparative H2A.X depositions in SNEL iPSC and OSKM iPSC at two chromosomes (left: Chr9; right: Chr10). y axis: relative H2A.X deposition level (RSEG
score, as compared to the ESC parental line, see Experimental Procedures). Positive value: regions enriched for H2A.X deposition over control (gray bars);
negative values: regions devoid of H2A.X deposition over control (blue bars).
(C) The bar chart illustrates that the genome coverage of H2A.X defective deposition regions in OSK-iPSC lines are significantly higher than those in SNEL-iPSC
lines (n = 2) (p value < 0.05, Wilcoxon rank sum test).
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Generation of High-Quality iPSCs(Buganim et al., 2012), produce iPSCs that have a considerably
higher competence to generate ‘‘all-iPSC’’ mice by 4n comple-
mentation than iPSCs produced by the conventional OSKM fac-
tors or other combinations such as OSK or OSSNE. The various
iPSC lines that were produced throughout this study were gener-
ated, isolated and tested under identical conditions to rule out
effects caused by variations in cell culture, method of factor de-
livery, the passage number of the lines, or blastocyst injections.
While reprogramming by OSKM produced many colonies with
shorter latency but with variable quality, reprogramming by
SNEL yielded significantly fewer iPSCs the majority of which,
however, were of high quality. This is reminiscent of previous
studies in which similar transgenic OSKM systems producingCell SiPSCs with different efficiencies resulted in different quality
iPSCs, with the more efficient system (Stadtfeld et al., 2010) pro-
ducing iPSCs of lower quality—as assessed by 4n complemen-
tation—than the less efficient system (Carey et al., 2011). These
two studies suggest that high reprogramming efficiency may
result in a low fraction of high-quality iPSCs.
To define molecular signature of 4n competency, we
compared the transcriptional profile of poor, good and high-
quality iPSCs. Genes involved in ‘‘Respiratory,’’ ‘‘Ischemia,’’
and ‘‘Myocardial infarction’’ separated high, good, and poor
quality iPSCs consistent with the observation that poor quality
iPSC lines produced ‘‘all-iPSC’’ pups that were either retarded
in development or died in utero. Importantly, neither DNAtem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier Inc. 305
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Generation of High-Quality iPSCsmethylation patterns, as revealed by whole genome bisulfite
sequencing, nor the transcript level of key master regulators
such as Oct4, Sox2, and Esrrb and the establishment of
ESC-specific superenhancers could explain the difference in
the transcriptional profile between the groups or could sepa-
rate the groups by 4n proficiency. Instead, we demonstrated
that a large number of OSKM/OSK-iPSCs acquire a unique
genomic aberration at least in some fraction of cells. While
the overall incidence of aneuploidy between MEFs, ESCs,
and poor- and high-quality iPSC colonies was comparable, tri-
somy of chromosome 8 was solely observed in iPSCs that
were produced with a combination of factors that includes
Oct4, Sox2, and Klf4. As shown previously, trisomy 8 ESCs
have a proliferative advantage but poor developmental poten-
tial (Liu et al., 1997). Consistent with the notion that expression
of OSKM or OSK leads to genome instability, we and others
(Gonza´lez et al., 2013) demonstrated that expression of
OSKM induces DNA damage as assessed by the accumulation
of g-H2A.X phosphorylation. This DNA damage led to cell
death in 17% (a sum of an early and late apoptotic cells)
of the OSKM-infected cells, showing that intense and, in
some cases, irreversible DNA damage is caused by this com-
bination of factors. In accordance with the accumulation of g-
H2A.X phosphorylation, the deposition of H2A.X throughout
the genome was abnormal in poor quality OSKM and OSK-
iPSCs, as well. More importantly, high-quality SNEL-iPSC lines
exhibited a significantly lower number of regions devoid of
H2A.X deposition as compared to control ESC line or high-
quality OSK-iPSC lines. Because histones regulate transcrip-
tion, it is tempting to speculate that the aberrant deposition
of H2A.X in poor quality iPSC lines might explain the mild dif-
ference in the gene expression between poor- and high-quality
iPSCs.
In summary, our study provides a proof of principle that
different combinations of reprogramming factors do not equally
affect the biological characteristics of iPSCs, with some combi-
nations consistently resulting in high-quality cells, whereas
others generate cells of variable quality. While genomic insta-
bility and the deposition of H2A.X partially explain why poor
quality iPSCs fail in the 4n complementation test, the reason
why most colonies from other combinations of factors, that
lack potent oncogenes such as OSSNE failed in this test,
requires further investigation. Our results indicate that the inter-
play between the reprogramming factors is a crucial determi-
nant for reprogramming efficiency and quality. This is consis-
tent with the observation that conversion of cells into other
cell types depends on the composition of reprogramming fac-
tors (Graf and Enver, 2009). Attempts to reprogram human cells
to pluripotency using SNEL reprogramming factors have so far
failed (data not shown), suggesting that the activation of the
core pluripotency circuitry of human cells might be different
than that of the mouse or that the reprogramming efficiency
of SNEL in human cells is drastically low so that one needs
to infect a large number of fibroblasts in order to achieve re-
programming. Based on these results it will be important to
define the most optimal factor combinations for reprogramming
and to assess how different factor combinations might affect
the quality of human iPSCs as a step forward toward transplan-
tation therapy.306 Cell Stem Cell 15, 295–309, September 4, 2014 ª2014 Elsevier IEXPERIMENTAL PROCEDURES
Cell Culture and Mice
Mouse embryonic fibroblasts (MEFs) were grown in DMEMsupplementedwith
10% fetal bovine serum, 2 mM L-glutamine, and antibiotics. ESCs and iPSCs
and were grown in DMEM supplemented with 15% fetal bovine serum, 1%
nonessential amino acids, 2 mM L-glutamine, 2 3 106 units mouse leukemia
inhibitory factor (mLif), 0.1 mM b-mercaptoethanol (Sigma), and antibiotics or
in 2i medium. 2i medium (500 ml) was generated by including: 230 ml DMEM/
F12 (Invitrogen; 11320), 230 ml Neurobasal medium (Invitrogen; 21103), 5 ml
N2 supplement (Invitrogen; 17502048), 10 ml B27 supplement (Invitrogen;
17504044), 10 ml (2%) fetal bovine serum, 23 106 units mLif, 1 mM glutamine
(Invitrogen), 1% nonessential amino acids (Invitrogen), 0.1 mM b-mercaptoe-
thanol (Sigma), penicillin-streptomycin (Invitrogen), 5 mg/ml BSA (Sigma),
PD0325901 (PD, 1 mM), and CHIR99021 (CH, 3 mM). All the cells were main-
tained in a humidified incubator at 37Cand 5%CO2. For the primary infection,
MEFs were isolated from mice heterozygous for the reverse tetracycline-
dependent transactivator (M2rtTA) that resides in the ubiquitously expressed
Gt(ROSA)26Sor locus (Beard et al., 2006) and either with GFP that was
knocked-in the Nanog or the Oct4 locus. All infections were performed on
MEFs (passage 0) that were seeded at 70% confluence 2 days before the first
infection. Animal care was in accordance with institutional guidelines and was
approved by the Committee on Animal Care, Department of Comparative
Medicine, Massachusetts Institute of Technology.
Tetraploid Embryo Complementation and Chimera Formation
Blastocyst injections were performed using (C57/Bl6xDBA) B6D2F2 host em-
bryos. All injected iPSC lines were derived from crosses of 129Sv/Jae to
C57/Bl6 mice and could be identified by agouti coat color. Embryos were
obtained 24 hr (1 cell stage) or 40 hr (2 cell stage) posthuman chorionic gonad-
otropin (hCG) hormone priming. To obtain tetraploid (4n) blastocysts, electrofu-
sion was performed at44–47 hr post-hCG using a BEX LF-101 or LF-301 cell
fusion apparatus (Protech International). Both fused and diploid embryos were
cultured in EmbryoMax KSOM (Millipore) or Evolve KSOMaa (Zenith Biotech)
until they formed blastocysts (94–98 hr after hCG injection) at which point
theywere placed in a drop of Evolvew/HEPESKSOMaa (Zenith)mediumunder
mineral oil. A flat tip microinjection pipette with an internal diameter of 16 mm
(Origio) was used for iPSC injections. Each blastocyst received 10–12 iPSCs.
Shortly after injection, blastocysts were transferred to day 2.5 recipient CD1
females (20blastocystsper female). Pups,whennot born naturally,were recov-
ered at day 19.5 by cesarean section and fostered to lactating Balb/c mothers.
SSLP Assay
PCR reactions were set up as previously described (Stadtfeld et al., 2012)
using genomic DNA from the 4n pups and primers reported to detect polymor-
phisms in the genome of inbred mouse strains (D8Mit94-F: GTTGGG
GCTCTGCTCTCTC; D8Mit94-R: CACATATGCATAC ATATACATACACGT;
D2Mit102-F: TTCCCTGTCACTCCTCCC; D2Mit102-R: TGTCTTT ATGCTCA
GACATACACA). As controls, genomic DNA was analyzed from cultured iPSCs
used for injections and adult mice (B6D2F1) that served as hosts for the blasto-
cysts. The reactions were performed with 100 ng DNA for 30 cycles of 30 s at
94C, 30 s at 60C, and 60 s at 72C. The products were analyzed on a 3%
agarose gel.
Gene Expression Microarrays
Two micrograms of RNA extracted using the RNeasy kit (QIAGEN) from each
iPSC and ESC were tested by Agilent BioAnalyzer assays to ensure sample
integrity. Technical duplicates of each sample were run on Agilent SurePrint
G3 8x60Kmicroarrays permanufacturer’s instructions. Raw expression values
were quantile normalized and binary log values of technical duplicate averages
used for downstream analyses.
Gene Expression Analyses
Standardized scoring was used to normalize microarray expression values. To
generate heatmaps, expression values were used as input to perform clus-
tering by samples in R, using the heatmap.2 function of the gplots library pack-
age with the default Euclidean distance parameter. In parallel, normalized
expression values were used to group samples by principle componentnc.
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Generation of High-Quality iPSCsanalysis using the R princomp function. Gene ontology analysis was per-
formed using the publicly available GeneDecks V3 software suite available
at http://www.genecards.org/.
Whole-Genome Bisulfite Library Preparation and Sequencing
Bisulfite treatment and sequencing library preparation were performed as pre-
viously described (Lister et al., 2011). Briefly, genomic DNA from each iPSC
and ESC was fragmented by sonication prior to ligation of methylated
sequencing adaptors. Fragments were size-selected by gel electrophoresis
and purification, treated with sodium-bisulfite and amplified with four cycles
of PCR to generate libraries that were sequenced on the Illumina HiSeq plat-
form. Fastq output files were aligned using bowtie (Langmead et al., 2009).
Illumina Sequencing
Libraries were pooled for sequencing and 200 to 400 bp size range fragments
were purified using a 2% E-Gel Agarose Gel (Invitrogen). DNA quality was as-
sessed and quantified on a High Sensitivity dsDNA kit (Agilent) on the Agilent
2100 Bio-Analyzer and on the Qubit 2.0 Fluorometer (Life Technologies). For
sequencing, clusters were generated on the CBot (HiSeq2500), and single-end
50bp readsweregeneratedusing theHiSeq2500sequencingplatform (Illumina).
Bioinformatic Analysis
Demultiplexed fastq files were aligned to themouse reference genome assem-
bly (GRCm38/mm10) using short read aligner Bowtie2 (version 2.0.5) (Lang-
mead and Salzberg, 2012) with default settings. Sorted and indexed bam files
were processed as previously described (Falconer et al., 2012) using the BAIT
software package (Hills et al., 2013). Briefly, diploid and aneuploid chromo-
somes were identified by calculating the average numbers of reads/Mb for
each chromosome in the library. Monosomies and trisomies were classified
when chromosomes had an average read count 0.663 lower or 1.333 higher,
respectively than the average reads per Mb for diploid chromosomes in the
library.
Statistics
The average frequency of trisomy 8 and aneuploidy per cell type was deter-
mined and p values were calculated using binomial distribution models.
Chromatin Immunoprecipitation for Med1 Distribution
Cells were crosslinked for 10 min at room temperature by the addition of one-
tenth of the volume of 11% formaldehyde solution (11% formaldehyde, 50mM
HEPES [pH 7.3], 100mMNaCl, 1 mMEDTA [pH 8.0], 0.5 mMEGTA [pH 8.0]) to
the growth media. Cells were washed twice with PBS, then the supernatant
was aspirated and the cell pellet was flash frozen in liquid nitrogen. Frozen
crosslinked cells were stored at80C. Dynal magnetic beads (100 ml) (Sigma)
were blocked with 0.5% BSA (w/v) in PBS. Magnetic beads were bound with
10 mg of the indicated antibody. For Med1 (CRSP1/TRAP220) occupied
genomic regions, we performed ChIP-seq experiments using a Bethyl Labora-
tories antibody (A300-793A, lot A300-783A-2) or a Santa Cruz Biotechnology
antibody (SC-5334X, lot A1112).
Crosslinked cells were lysed with lysis buffer 1 (50 mM HEPES [pH 7.3],
140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, and 0.25% Triton
X-100) and resuspended and sonicated in sonication buffer (20 mM Tris-HCl
[pH 8.0], 150 mM NaCl, 2 mM EDTA [pH 8.0], 0.1% SDS, and 1% Triton
X-100). Cells were sonicated for ten cycles at 30 s each on ice (18–21 W)
with 60 s on ice between cycles. Sonicated lysates were cleared and incu-
bated overnight at 4C with magnetic beads bound with antibody to enrich
for DNA fragments bound by the indicated factor. Beads were washed two
times with sonication buffer, one time with sonication buffer with 500 mM
NaCl, one time with LiCl wash buffer (10 mM Tris [pH 8.0], 1 mM EDTA,
250 mM LiCl, 1% NP-40), and one time with TE with 50 mM NaCl. DNA was
eluted in elution buffer (50 mM Tris-HCL [pH 8.0], 10 mM EDTA, 1% SDS).
Crosslinks were reversed overnight. RNA and protein were digested using
RNase A and Proteinase K, respectively, and DNA was purified with phenol
chloroform extraction and ethanol precipitation.
Illumina Sequencing and Library Generation
Purified ChIP DNA was used to prepare Illumina multiplexed sequencing
libraries. Libraries for Illumina sequencing were prepared following the Illu-Cell Smina TruSeq DNA Sample Preparation v2 kit protocol with the following
exceptions. After end-repair and A-tailing, immunoprecipitated DNA (10–
50 ng) or Whole Cell Extract DNA (50 ng) was ligated to a 1:50 dilution of Illu-
mina Adaptor Oligo Mix assigning one of 24 unique indexes in the kit to each
sample. Following ligation, libraries were amplified by 18 cycles of PCR using
the HiFi NGS Library Amplification kit from KAPA Biosystems. Amplified
libraries were then size-selected using a 2% gel cassette in the Pippin Prep
system from Sage Science set to capture fragments between 200 and
400 bp. Libraries were quantified by qPCR using the KAPA Biosystems Illu-
mina Library Quantification kit according to kit protocols. Libraries with
distinct TruSeq indexes were multiplexed by mixing at equimolar ratios and
running together in a lane on the Illumina HiSeq 2000 for 40 bases in single
read mode.
ChIP-seq Analysis
Mouse ESC superenhancers were downloaded from Whyte et al. (2013).
Briefly, these superenhancers were identified by (1) intersecting regions en-
riched in Oct4, Sox2, and Nanog ChIP-seq to locate constituent enhancers,
(2) stitching proximal enhancers into domains, and (3) separating superen-
hancers from typical enhancers by signal of Med1.
ChIP-seq reads for Med1 in all cell types were aligned to the mouse mm9
reference genome using bowtie (Langmead et al., 2009) with command-line
parameters -k 1 -m 1–best -n 2. Duplicate (multiple reads per position) reads
were removed. Reads were artificially extended 200 bp downstream and their
reads-per-million normalized density was calculated in mES superenhancers
as described in (Lin et al., 2012). These densities were then hierarchically clus-
tered in two dimensions using heatmap.2.
ACCESSION NUMBERS
The accession number for the data resulting from whole-genome bisulfite
sequencing as discussed in the text is GSE59696; for Mediator ChIP
Sequencing, GSE59569; for whole-transcriptome analysis, GSE45173; and
for H2A.X ChIP sequencing, GSE55731.
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